Insiders Alvotech

Equities

ALVO

LU2458332611

End-of-day quote Nasdaq Other stock markets 06:00:00 2024-05-07 pm EDT			5-day change	1st Jan Change
13.54 ^USD	-2.31%		-6.49%	+17.94%

Apr. 30	Alvotech to Manufacture Humira Biosimilar for Quallent Pharmaceuticals	MT
Apr. 30	Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Alvotech Announces Executive Changes	Feb. 29	CI
Alvotech Names Faysal Kalmoua as COO	23-09-05	MT
Alvotech Names New COO	23-09-05	MT
Alvotech Announces Changes to the Leadership Team	23-09-05	CI
Debt Ceiling Deal in Focus Amid Rising Exchange-Traded Funds, Equity Futures Pre-Bell Friday	23-05-19	MT
Biosimilar Maker Alvotech Names New Chief Quality Officer	23-04-20	MT
Sarah Tanksley Joins Board of Directors for Alvotech hf. and Sandra Casaca Appointed Chief Quality Officer	23-04-19	GL
Sarah Tanksley Joins Board of Directors for Alvotech hf. and Sandra Casaca Appointed Chief Quality Officer	23-04-19	AQ
Alvotech Appoints Sandra Casaca as Chief Quality Officer	23-04-19	CI
Alvotech Chief Executive to Leave; Executive Chairman Named CEO	22-12-02	MT
Alvotech Appoints Hafrun Fridriksdottir as Chief Operating Officer, Effective January 1, 2023	22-12-01	CI
Alvotech Announces Executive Changes, Effective January 1, 2023	22-12-01	CI
Alvotech Names New Chief Quality Officer	22-10-12	MT
Alvotech Announces Executive Changes	22-10-11	CI
Alvotech Expands its Board of Directors as Part of Transition from Private to Publicly Traded Company	22-07-14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW